Other oral symptoms (dysgeusia, dysphagia) · Patients with radiation-induced salivary gland dysfunction
1 finding from 1 review
Femoral neck bone mineral density (FN-BMD) · patients with osteoporosis
1 finding from 1 review
BMD of femoral neck (Shengu capsule versus no intervention) · patients with osteoporosis
1 finding from 1 review
Femoral neck bone mineral density (FN-BMD) · patients with osteoporosis
1 finding from 1 review
Maintenance of clinical remission · Participants with Crohn's disease in remission
Methotrexate showed no clear difference in proportion of patients maintaining clinical remission (low dose oral… compared with placebo (low certainty).
1 finding from 1 review
Number of participants with worsening scores in corporal atrophy · people with pre‐malignant lesions
Proton pump inhibitor showed no clear difference in number of participants with worsening scores in corporal atrophy compared with control (low certainty).
1 finding from 1 review
Number of participants with worsening scores in corporal intestinal metaplasia · people with pre‐malignant lesions
Proton pump inhibitor showed no clear difference in number of participants with worsening scores in corporal intestinal… compared with control (low certainty).
1 finding from 1 review
Intervention not reported
Asthma exacerbation as defined by hospital admission or treatment with a course of oral corticosteroids · participants with asthma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Asthma exacerbation as defined by hospital admission or treatment with a course of oral corticosteroids · participants with exercise‐induced asthma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Oral health assessment · Adults with dry mouth due to radiotherapy (head and neck cancer) or Sjogren's Syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
0 studies
No studies found
Oral health assessment · Adults with dry mouth due to Sjogren's Syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
0 studies
No studies found
Adverse effects / specific side effects (oral allergic reactions, mucosal irritation, adverse symptoms such as nausea, gagging, vomiting) · Children and adolescents aged 16 years or less
1 finding from 1 review
Intervention not reported
Length of stay (days) ‐ oral anticoagulants · saving healthcare resources
1 finding from 1 review
Intervention not reported
Oral anticoagulants: time in target INR range (%) · patients with leading physiological parameters within therapeutic range
1 finding from 1 review
Intervention not reported
Time to achieve therapeutic range ‐ oral anticoagulants: time to achieve therapeutic prothrombin ratio (days) · patients with reducing time to achieve therapeutic control
1 finding from 1 review
Intervention not reported
Time to stabilization ‐ oral anticoagulants: time to stabilization (days) · patients with reducing time to achieve therapeutic control
1 finding from 1 review
Mean exacerbations requiring a course of oral corticosteroids · asthmatics with sensitivity to house dust mite
MHRV showed no clear difference in exacerbations needing oral steroids compared with placebo (moderate certainty).
1 finding from 1 review
Exacerbations requiring a course of oral or inhaled corticosteroids or emergency department visits · people with asthma
The review found no eligible studies for this question.
1 finding from 1 review
Rate of exacerbations requiring systemic corticosteroids · adults with asthma not well controlled on ICS
160/4.5 mcg BDF single inhaler therapy probably leads to lower patients with exacerbations treated with oral steroids compared with current best practice (moderate certainty).
1 finding from 1 review
Rate of exacerbations requiring systemic corticosteroids · adults with asthma not well controlled on ICS
Single inhaler therapy leads to lower patients with exacerbations treated with oral steroids compared with fixed dose ICS (high certainty).
1 finding from 1 review